TRPM8 agonist (cryosim-1) gel for scalp itch: a randomised, vehicle-controlled clinical trial

J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e588-e589. doi: 10.1111/jdv.18080. Epub 2022 Mar 24.

Authors

S Y Kang¹, M G Choi², E T Wei³, T Selescu⁴, S Y Lee¹, J C Kim¹, B Y Chung¹, C W Park¹, H O Kim¹

Affiliations

¹ Department of Dermatology, Kangnam Sacred Heart Hospital, Hallym University, Seoul, Korea.
² Department of Computer Science and Engineering, Kwangwoon University, Seoul, Korea.
³ School of Public Health, University of California, Berkeley, CA, USA.
⁴ Department of Anatomy, Physiology and Biophysics, Faculty of Biology, University of Bucharest, Bucuresti, Romania.

PMID: 35293031
DOI: 10.1111/jdv.18080

No abstract available

Publication types

Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Membrane Proteins
Pruritus / drug therapy
Scalp*
TRPM Cation Channels*

Substances

Membrane Proteins
TRPM Cation Channels
TRPM8 channel-associated factor 1 protein, human
TRPM8 protein, human

Grants and funding

The study has been supported by grants from the National Research Foundation of Korea (NRF-2022R1A2C2007739) and the Research Grant of Kwangwoon University in 2020